Difference between revisions of "FOXO3a"

From Aging Chart
Jump to: navigation, search
(Autoloading by CXLParser)
(Autoloading by CXLParser)
 
Line 188: Line 188:
 
(.//.)<html><!--Pop-up for: Lack of growth factors !Pop-up-->
 
(.//.)<html><!--Pop-up for: Lack of growth factors !Pop-up-->
 
<div class="1NLC3J0JQ-1CJJ8Z9-4FJ" style="display:none;">
 
<div class="1NLC3J0JQ-1CJJ8Z9-4FJ" style="display:none;">
 +
  
 
<h3>Lack of growth factors</h3>
 
<h3>Lack of growth factors</h3>
<div class="links"><a href=" ">Lack of growth factors</a><br /></div>
+
<div class="links"><a href="No links!"></a><br /><a href=" ">Lack of growth factors</a><br /></div>
 
</div>(...)<!--Pop-up for: Oxidative stress !Pop-up-->
 
</div>(...)<!--Pop-up for: Oxidative stress !Pop-up-->
 
<div class="1NLC3J0JW-2474QX8-4H2" style="display:none;">
 
<div class="1NLC3J0JW-2474QX8-4H2" style="display:none;">
 +
  
 
<h3>Oxidative stress</h3>
 
<h3>Oxidative stress</h3>
Line 198: Line 200:
 
</div>(...)<!--Pop-up for: Antioxidant enzymes !Pop-up-->
 
</div>(...)<!--Pop-up for: Antioxidant enzymes !Pop-up-->
 
<div class="1NLC3J0JS-1JPF46N-4G9" style="display:none;">
 
<div class="1NLC3J0JS-1JPF46N-4G9" style="display:none;">
 +
  
 
<h3>Antioxidant enzymes</h3>
 
<h3>Antioxidant enzymes</h3>
Line 203: Line 206:
 
</div>(...)<!--Pop-up for: Genotoxic stress !Pop-up-->
 
</div>(...)<!--Pop-up for: Genotoxic stress !Pop-up-->
 
<div class="1NLC3J0JQ-M3MTQH-4FC" style="display:none;">
 
<div class="1NLC3J0JQ-M3MTQH-4FC" style="display:none;">
 +
  
 
<h3>Genotoxic stress</h3>
 
<h3>Genotoxic stress</h3>
Line 208: Line 212:
 
</div>(...)<!--Pop-up for: Ddb1 !Pop-up-->
 
</div>(...)<!--Pop-up for: Ddb1 !Pop-up-->
 
<div class="1NLC3J0JT-268VWYV-4GH" style="display:none;">
 
<div class="1NLC3J0JT-268VWYV-4GH" style="display:none;">
 +
  
 
<h3>Ddb1</h3>
 
<h3>Ddb1</h3>
Line 213: Line 218:
 
</div>(...)<!--Pop-up for: Proapoptotic proteins !Pop-up-->
 
</div>(...)<!--Pop-up for: Proapoptotic proteins !Pop-up-->
 
<div class="1NLC3J0JR-28FDH7B-4FX" style="display:none;">
 
<div class="1NLC3J0JR-28FDH7B-4FX" style="display:none;">
 +
  
 
<h3>Proapoptotic proteins</h3>
 
<h3>Proapoptotic proteins</h3>
<div class="links"><a href=" ">Proapoptotic proteins</a><br /></div>
+
<div class="links"><a href="No links!"></a><br /><a href=" ">Proapoptotic proteins</a><br /></div>
 
</div>(...)<!--Pop-up for: Pparg !Pop-up-->
 
</div>(...)<!--Pop-up for: Pparg !Pop-up-->
 
<div class="1NLC3J0JV-20KL5L1-4GZ" style="display:none;">
 
<div class="1NLC3J0JV-20KL5L1-4GZ" style="display:none;">
 +
  
 
<h3>Pparg</h3>
 
<h3>Pparg</h3>
<div class="links"><a href=" ">Pparg</a><br /></div>
+
<div class="links"><a href="No links!"></a><br /><a href=" ">Pparg</a><br /></div>
 
</div>(...)<!--Pop-up for: Heat shock proteins !Pop-up-->
 
</div>(...)<!--Pop-up for: Heat shock proteins !Pop-up-->
 
<div class="1NLC3J0JT-1ZKVFC9-4GL" style="display:none;">
 
<div class="1NLC3J0JT-1ZKVFC9-4GL" style="display:none;">
 +
  
 
<h3>Heat shock proteins</h3>
 
<h3>Heat shock proteins</h3>
Line 228: Line 236:
 
</div>(...)<!--Pop-up for: Catalase !Pop-up-->
 
</div>(...)<!--Pop-up for: Catalase !Pop-up-->
 
<div class="1NLC3J0JV-3Z5FDX-4GS" style="display:none;">
 
<div class="1NLC3J0JV-3Z5FDX-4GS" style="display:none;">
 +
  
 
<h3>Catalase</h3>
 
<h3>Catalase</h3>
Line 233: Line 242:
 
</div>(...)<!--Pop-up for: EGF !Pop-up-->
 
</div>(...)<!--Pop-up for: EGF !Pop-up-->
 
<div class="1NLC3J0JR-5NBRSH-4FT" style="display:none;">
 
<div class="1NLC3J0JR-5NBRSH-4FT" style="display:none;">
 +
  
 
<h3>EGF</h3>
 
<h3>EGF</h3>
Line 238: Line 248:
 
</div>(...)<!--Pop-up for: FOXO3a !Pop-up-->
 
</div>(...)<!--Pop-up for: FOXO3a !Pop-up-->
 
<div class="1NLC3J0JR-ZDXQ6H-4FQ" style="display:none;">
 
<div class="1NLC3J0JR-ZDXQ6H-4FQ" style="display:none;">
 +
  
 
<h3>FOXO3a</h3>
 
<h3>FOXO3a</h3>
Line 243: Line 254:
 
</div>(...)<!--Pop-up for: Metabolism regulators !Pop-up-->
 
</div>(...)<!--Pop-up for: Metabolism regulators !Pop-up-->
 
<div class="1NLC3J0JT-150SB6S-4GD" style="display:none;">
 
<div class="1NLC3J0JT-150SB6S-4GD" style="display:none;">
 +
  
 
<h3>Metabolism regulators</h3>
 
<h3>Metabolism regulators</h3>
Line 248: Line 260:
 
</div>(...)<!--Pop-up for: SOD2 !Pop-up-->
 
</div>(...)<!--Pop-up for: SOD2 !Pop-up-->
 
<div class="1NLC3J0JV-25938RN-4GP" style="display:none;">
 
<div class="1NLC3J0JV-25938RN-4GP" style="display:none;">
 +
  
 
<h3>SOD2</h3>
 
<h3>SOD2</h3>
Line 253: Line 266:
 
</div>(...)<!--Pop-up for: Gadd45a !Pop-up-->
 
</div>(...)<!--Pop-up for: Gadd45a !Pop-up-->
 
<div class="1NLC3J0JS-Z7N5S0-4G6" style="display:none;">
 
<div class="1NLC3J0JS-Z7N5S0-4G6" style="display:none;">
 +
  
 
<h3>Gadd45a</h3>
 
<h3>Gadd45a</h3>
Line 258: Line 272:
 
</div>(...)<!--Pop-up for: PUMA !Pop-up-->
 
</div>(...)<!--Pop-up for: PUMA !Pop-up-->
 
<div class="1NLC3J0JS-106SJ0Q-4G3" style="display:none;">
 
<div class="1NLC3J0JS-106SJ0Q-4G3" style="display:none;">
 +
  
 
<h3>PUMA</h3>
 
<h3>PUMA</h3>
Line 263: Line 278:
 
</div>(...)<!--Pop-up for: Bcl2l11 !Pop-up-->
 
</div>(...)<!--Pop-up for: Bcl2l11 !Pop-up-->
 
<div class="1NLC3J0JW-Z3LNRJ-4H5" style="display:none;">
 
<div class="1NLC3J0JW-Z3LNRJ-4H5" style="display:none;">
 +
  
 
<h3>Bcl2l11</h3>
 
<h3>Bcl2l11</h3>
Line 268: Line 284:
 
</div>(...)<!--Pop-up for: Hspa1b !Pop-up-->
 
</div>(...)<!--Pop-up for: Hspa1b !Pop-up-->
 
<div class="1NLC3J0JW-376389-4H8" style="display:none;">
 
<div class="1NLC3J0JW-376389-4H8" style="display:none;">
 +
  
 
<h3>Hspa1b</h3>
 
<h3>Hspa1b</h3>
Line 273: Line 290:
 
</div>(...)<!--Pop-up for: IGF-1 !Pop-up-->
 
</div>(...)<!--Pop-up for: IGF-1 !Pop-up-->
 
<div class="1NLC3J0JR-L8B8G7-4FM" style="display:none;">
 
<div class="1NLC3J0JR-L8B8G7-4FM" style="display:none;">
 +
  
 
<h3>IGF-1</h3>
 
<h3>IGF-1</h3>
Line 278: Line 296:
 
</div>(...)<!--Pop-up for: G6pc !Pop-up-->
 
</div>(...)<!--Pop-up for: G6pc !Pop-up-->
 
<div class="1NLC3J0JV-1QRHP97-4GW" style="display:none;">
 
<div class="1NLC3J0JV-1QRHP97-4GW" style="display:none;">
 +
  
 
<h3>G6pc</h3>
 
<h3>G6pc</h3>
Line 283: Line 302:
 
</div>(...)<!--Pop-up for: Response to DNA damage !Pop-up-->
 
</div>(...)<!--Pop-up for: Response to DNA damage !Pop-up-->
 
<div class="1NLC3J0JS-87P6LR-4G0" style="display:none;">
 
<div class="1NLC3J0JS-87P6LR-4G0" style="display:none;">
 +
  
 
<h3>Response to DNA damage</h3>
 
<h3>Response to DNA damage</h3>

Latest revision as of 09:26, 2 August 2015

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

FOXO3a

FOXO transcription factors belong to the forkhead family of transcriptional regulators that is characterized by a conserved DNA binding domain termed the ‘‘forkhead box’’. FOXO proteins are normally present in an active state in a cell’s nucleus. In response to the binding of growth factors or insulin to the appropriate cell surface receptors, the activation of phosphatidylinositol 3-kinase (PI3K) is triggered. PI3K in turn activates several serine/threonine kinases, including protein kinase B (PKB/Akt) and the related SGK family enzymes. Activated Akt phosphorylates FOXO proteins at three consensus Akt phosphorylation sites, triggering the inactivation of these molecules and their export from the nucleus into the cytoplasm.

FOXO proteins have both distinct and overlapping functions, and their many target molecules are involved in processes as diverse as cell-cycle, DNA repair, cellular differentiation, and cell death. In proliferating cells, protection from cell death is mediated by activity of the phosphatidylinositol-3-OH kinase (PI(3)K)–PKB signalling pathway, which is dependent on the presence of glucose. In the absence of PI(3)K–PKB signalling, the FOXO subfamily of Forkhead transcription factors is activated. In most cell types, this leads to cell-cycle arrest and quiescence but not apoptosis, despite the absence of PKB activity.

Stimulation of SIRT1 transcription by FOXO3A was mediated through two p53 binding sites present in the SIRT1 promoter, and a nutrient-sensitive physical interaction was observed between FOXO3A and p53. SIRT1 expression was not induced in starved p53-deficient mice. Thus, in mammalian cells, p53, FOXO3A, and SIRT1, 3 proteins separately implicated in aging, constitute a nutrient-sensing pathway. Long-lived men presented several additional phenotypes linked to healthy aging. Several of these aging phenotypes were associated with the FOXO3A genotype. Long-lived men also exhibited several biologic markers indicative of greater insulin sensitivity, and this was associated with homozygosity for the FOXO3A GG genotype.